Table 3 Serum sTLR4 and sCD14 levels in patients with COVID-19
From: Serum soluble toll-like receptor 4 and risk for clinical severity in COVID-19 patients
|  | NSCP group(n = 28) | SCP group (n = 70) |  |
|---|---|---|---|
Median [IQR] | Median [IQR] | P | |
Immunological Biomarkers | |||
 sCD14 (mg/L) | 0.71 [0.52] | 0.85 [0.41] | 0.011 |
 sTLR4 (ng/ml) | 0.96 [0.87] | 1.18 [0.28] | 0.017 |